Nexus Bio Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.76 Cr
- Revenue Growth 89.39%
- Profit Growth 112.08%
- Ebitda 70.62%
- Net Worth 37.14%
- Total Assets 15.39%
About Nexus Bio Science
Nexus Bio Science Private Limited (NBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2018 (Seven years and one month 8 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹7.76 Cr.
Jyotsanaben Patel and Ved Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2018PTC100418
-
Company No.
100418
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Nexus Bio Science Private Limited offer?
Nexus Bio Science Private Limited offers a wide range of products and services, including Insecticides and Pesticides, Termiticide, Insecticides, Herbicides, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Plant Growth Promoters, Micronutrient Fertilizers, Selective Herbicide, Acaricide.
Who are the key members and board of directors at Nexus Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotsanaben Patel
|
Director | 05-Jan-2018 | Current |
|
Ved Patel
|
Additional Director | 16-May-2024 | Current |
Financial Performance of Nexus Bio Science.
Nexus Bio Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 89.39% increase. The company also saw a substantial improvement in profitability, with a 112.08% increase in profit. The company's net worth Soared by an impressive increase of 37.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexus Bio Science?
In 2023, Nexus Bio Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Amul Insecticides Private LimitedJyotsanaben Patel is a mutual person
Charges (Loans)
₹77.57 M
₹0
Charges Breakdown by Lending Institutions
- Others : 6.51 Cr
- Hdfc Bank Limited : 1.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2024 | Hdfc Bank Limited | ₹1.90 M | Open |
| 10 Jul 2024 | Hdfc Bank Limited | ₹0.71 M | Open |
| 21 May 2024 | Hdfc Bank Limited | ₹1.11 M | Open |
| 08 Apr 2024 | Others | ₹6.51 Cr | Open |
| 17 May 2023 | Hdfc Bank Limited | ₹1.77 M | Open |
How Many Employees Work at Nexus Bio Science?
Nexus Bio Science has a workforce of 91 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexus Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
